227 related articles for article (PubMed ID: 29615965)
1. Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.
Diederich JM; Staudt M; Meisel C; Hahn K; Meinl E; Meisel A; Klehmet J
Front Neurol; 2018; 9():171. PubMed ID: 29615965
[TBL] [Abstract][Full Text] [Related]
2. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
3. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
[TBL] [Abstract][Full Text] [Related]
5. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
6. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy.
Koike H; Katsuno M
Neurol Ther; 2020 Dec; 9(2):213-227. PubMed ID: 32410146
[TBL] [Abstract][Full Text] [Related]
8. Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP.
Klehmet J; Staudt M; Diederich JM; Siebert E; Meinl E; Harms L; Meisel A
Front Neurol; 2017; 8():724. PubMed ID: 29312139
[TBL] [Abstract][Full Text] [Related]
9. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
J Neurol; 2024 May; ():. PubMed ID: 38771386
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
11. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
[TBL] [Abstract][Full Text] [Related]
12. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
13. Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
Shibuya K; Tsuneyama A; Misawa S; Sekiguchi Y; Beppu M; Suichi T; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neuroimmunol; 2020 Apr; 341():577170. PubMed ID: 32006783
[TBL] [Abstract][Full Text] [Related]
14. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
Iijima M
Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
[TBL] [Abstract][Full Text] [Related]
15. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
[TBL] [Abstract][Full Text] [Related]
16. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
Ikeda S; Koike H; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
[TBL] [Abstract][Full Text] [Related]
18. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.
Ogata H; Yamasaki R; Hiwatashi A; Oka N; Kawamura N; Matsuse D; Kuwahara M; Suzuki H; Kusunoki S; Fujimoto Y; Ikezoe K; Kishida H; Tanaka F; Matsushita T; Murai H; Kira J
Ann Clin Transl Neurol; 2015 Oct; 2(10):960-71. PubMed ID: 26478896
[TBL] [Abstract][Full Text] [Related]
19. Treatment Approaches for Atypical CIDP.
Menon D; Katzberg HD; Bril V
Front Neurol; 2021; 12():653734. PubMed ID: 33790853
[TBL] [Abstract][Full Text] [Related]
20. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
